Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
116.30
-1.60 (-1.36%)
Jul 24, 2025, 3:13 PM AST

TADAWUL:4016 Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,3262,436----
Enterprise Value
2,3552,496----
Last Close Price
116.30120.65----
PE Ratio
25.8830.51----
Forward PE
24.0524.86----
PS Ratio
5.606.18----
PB Ratio
6.006.62----
P/TBV Ratio
6.937.67----
P/FCF Ratio
140.66100.97----
P/OCF Ratio
84.9469.02----
EV/Sales Ratio
5.676.33----
EV/EBITDA Ratio
21.4325.19----
EV/EBIT Ratio
23.7227.95----
EV/FCF Ratio
142.39103.45----
Debt / Equity Ratio
0.160.180.200.300.330.25
Debt / EBITDA Ratio
0.570.660.731.111.050.72
Debt / FCF Ratio
3.782.710.861.443.445.49
Asset Turnover
0.830.800.760.700.73-
Inventory Turnover
1.751.681.441.371.45-
Quick Ratio
1.931.851.491.361.591.52
Current Ratio
2.752.652.362.222.302.66
Return on Equity (ROE)
25.57%23.67%22.44%21.72%25.52%-
Return on Assets (ROA)
12.36%11.39%10.83%10.10%12.09%-
Return on Capital (ROIC)
15.24%13.91%13.21%12.06%14.23%-
Return on Capital Employed (ROCE)
24.10%22.70%23.40%22.30%25.40%28.20%
Earnings Yield
3.86%3.28%----
FCF Yield
0.71%0.99%----
Dividend Yield
2.15%1.66%----
Payout Ratio
16.69%18.79%54.69%61.14%56.12%49.80%
Total Shareholder Return
2.15%1.66%----
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.